On Monday, uniQure N.V (NASDAQ: QURE) opened lower -5.12% from the last session, before settling in for the closing price of $5.86. Price fluctuations for QURE have ranged from $3.73 to $11.35 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 302.35% over the last five years. Company’s average yearly earnings per share was noted 33.86% at the time writing. With a float of $45.29 million, this company’s outstanding shares have now reached $47.83 million.
The firm has a total of 480 workers. Let’s measure their productivity. In terms of profitability, gross margin is -14.87%, operating margin of -889.25%, and the pretax margin is -1011.03%.
uniQure N.V (QURE) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of uniQure N.V is 6.99%, while institutional ownership is 68.75%. The most recent insider transaction that took place on Jun 26 ’24, was worth 6,309. In this transaction Chief Medical Officer of this company sold 1,447 shares at a rate of $4.36, taking the stock ownership to the 115,253 shares. Before that another transaction happened on Jun 17 ’24, when Company’s Chief Operating Officer sold 2,936 for $4.81, making the entire transaction worth $14,122. This insider now owns 115,707 shares in total.
uniQure N.V (QURE) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 33.86% per share during the next fiscal year.
uniQure N.V (NASDAQ: QURE) Trading Performance Indicators
Check out the current performance indicators for uniQure N.V (QURE). In the past quarter, the stock posted a quick ratio of 7.36. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.92, a number that is poised to hit -0.99 in the next quarter and is forecasted to reach -2.94 in one year’s time.
Technical Analysis of uniQure N.V (QURE)
Analysing the last 5-days average volume posted by the [uniQure N.V, QURE], we can find that recorded value of 0.54 million was lower than the volume posted last year of 1.42 million. As of the previous 9 days, the stock’s Stochastic %D was 5.21%. Additionally, its Average True Range was 0.44.
During the past 100 days, uniQure N.V’s (QURE) raw stochastic average was set at 24.02%, which indicates a significant increase from 2.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.09% in the past 14 days, which was lower than the 134.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.69, while its 200-day Moving Average is $5.69. Now, the first resistance to watch is $5.79. This is followed by the second major resistance level at $6.03. The third major resistance level sits at $6.16. If the price goes on to break the first support level at $5.42, it is likely to go to the next support level at $5.29. Now, if the price goes above the second support level, the third support stands at $5.05.
uniQure N.V (NASDAQ: QURE) Key Stats
There are currently 48,698K shares outstanding in the company with a market cap of 277.39 million. Presently, the company’s annual sales total 15,840 K according to its annual income of -308,480 K. Last quarter, the company’s sales amounted to 11,130 K and its income totaled -56,300 K.
